Blue Fin Group supports pharmaceutical and life sciences companies throughout the product lifecycle developing strategies to optimize patient access. As products have evolved from primary care to specialty, patients face barriers to their therapies because they don't receive the type of support to navigate their insurance, their out-of-pocket expenses, and even knowing where to go for physical access to product.
We help our clients align all the elements of marketing, market access, field sales, pharmacy and distribution and patient services work as a seamless commercial strategy that helps optimize patient outcomes. We are a full service management consulting firm with skills in research, strategy and implementation.
We help our clients align all the elements of marketing, market access, field sales, pharmacy and distribution and patient services work as a seamless commercial strategy that helps optimize patient outcomes. We are a full service management consulting firm with skills in research, strategy and implementation.
Services
Our founder started our company after spending years working with pharmaceutical manufacturers helping them understand the full economic flow to their products. Our first client was a top 5 pharma company that wanted to overhaul their channel strategy for a $16B portfolio. Blue Fin Group set out to create a new kind of consulting firm.
Blue Fin Group is a management consulting firm whose mission is to collaborate with healthcare companies of all sizes and stages, enabling them to achieve their strategic, operational, and financial potential. Our passion is connecting patients to products with a keen focus on the patient journey. Blue Fin focuses on long-range strategy, delivering a 5-year, multigenerational plan at the conclusion of each engagement.
We provide research with all of our strategy engagements but sometimes a client doesn't want to commit to a new strategy without better understanding the situation or the market they are considering. That's when research itself is the project. Blue Fin Group has tenured primary and secondary market researchers that can help assess and analyze situations inside a company or externally in their markets.
Marketing teams are challenged to understand how all the moving pieces across product, patient, provider, payer and pharmacy work. With our cross-functional approach to commercialization, Blue Fin Group helps pharmaceutical manufacturers take commercialization from concept, to launch to loss of exclusivity.
Pharmacies typically approach Blue Fin Group in regards to having us evaluate their model in regards to how well they are optimizing the patient journey, which therapeutic areas they should focus on, or how to ensure manufacturers are aware and understand their value proposition.
As Blue Fin Group works with 29 of the top 30 pharmaceutical companies and over 300 manufacturers across all product archetypes, therapeutic areas, drug classes and benefit designs, we are particularly adept at helping them with their model and how they market.Consequently, Blue Fin Group has worked with all the nation's leading retailers, specialty, and hospital pharmacies providing an insider's view to how this channel thinks and operates.
As Blue Fin Group works with 29 of the top 30 pharmaceutical companies and over 300 manufacturers across all product archetypes, therapeutic areas, drug classes and benefit designs, we are particularly adept at helping them with their model and how they market.Consequently, Blue Fin Group has worked with all the nation's leading retailers, specialty, and hospital pharmacies providing an insider's view to how this channel thinks and operates.
Reviews
Be the first to review Blue Fin Group.
Write a Review
